Compounds > liarozole
Page last updated: 2024-08-24

liarozole and Uterine Neoplasms

liarozole has been researched along with Uterine Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Britten, J; Catherino, WH; Gilden, M; Levy, G; Malik, M; Segars, J1
Britten, J; Catherino, WH; Delgado, T; Gilden, M; Levy, G; Malik, M1

Other Studies

2 other study(ies) available for liarozole and Uterine Neoplasms

ArticleYear
Liarozole inhibits transforming growth factor-β3--mediated extracellular matrix formation in human three-dimensional leiomyoma cultures.
    Fertility and sterility, 2014, Volume: 102, Issue:1

    Topics: Antineoplastic Agents, Hormonal; Cell Culture Techniques; Collagen Type I; Collagen Type I, alpha 1 Chain; Down-Regulation; Extracellular Matrix; Female; Fibronectins; Humans; Imidazoles; Leiomyoma; Myometrium; Transforming Growth Factor beta3; Tumor Cells, Cultured; Uterine Neoplasms; Versicans

2014
Leiomyoma fibrosis inhibited by liarozole, a retinoic acid metabolic blocking agent.
    Fertility and sterility, 2012, Volume: 98, Issue:6

    Topics: Antineoplastic Agents, Hormonal; Cell Proliferation; Dose-Response Relationship, Drug; Extracellular Matrix; Extracellular Matrix Proteins; Female; Humans; Imidazoles; Leiomyoma; Tretinoin; Tumor Cells, Cultured; Uterine Neoplasms

2012